Author
1. Srivastava Sushma
ISBN
9789350252062
DOI
10.5005/jp/books/11442_8
Edition
1/e
Publishing Year
2011
Pages
11
Author Affiliations
1.
Delhi Institute of Pharmaceutical Sciences and Research (DIPSAR), MB Road, Pushp Vihar, Sector-3, New Delhi (India),
All India Institute of Medical Sciences, Ansari Nagar, New Delhi-110029, India,
Delhi Institute of Pharmaceutical, Sciences and Research, Pushp Vihar, Sector -3, New Delhi, India,
Delhi Institute of Pharmaceutical, Sciences and Research, Pushp Vihar Sector-3, New Delhi, India,
Delhi Institute of Pharmaceutical Sciences and Research (DIPSAR), University of Delhi, New Delhi, India,
Delhi Institute of Pharmaceutical Sciences and Research, University of Delhi, Pushp Vihar, Sector-3, New Delhi, India,
Indian Pharmacopoeia Commission, Ministry of Health and Family Welfare, Government of India, Ghaziabad, Uttar Pradesh, India
Chapter keywords
International drug monitoring,
adverse drug reactions,
thalidomide tragedy,
Uppsala monitoring center,
pharmacovigilance,
clinical pharmacology,
clinical pharmacy,
clinical toxicology,
pharmacovigilance center,
pharmacovigilance system,
human resource,
advisory committee,
communication,
drug-monitoring center,
poison control unit,
clinical pharmacology department,
hospital pharmacy,
ADR reporting,
adverse event,
risk factors,
health care professionals,
regulatory action,
drug regulation,
health insurance companies,
national health authorities,
international pharmacovigilance regulatory authorities
